|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin H, Bray F and Forman D:
Cancer incidence and mortality worldwide: IARC cancer base no. 10.
Int J Cancer J Int Du Cancer. 136:E359–E386. 2015. View Article : Google Scholar
|
|
3
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the human
development index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fucito LM, Czabafy S, Hendricks PS, Kotsen
C, Richardson D and Toll BA; Association for the Treatment of
Tobacco Use and Dependence/Society for Research on Nicotine and
Tobacco Synergy Committee, : Pairing smoking-cessation services
with lung cancer screening: A clinical guideline from the
association for the treatment of tobacco use and dependence and the
society for research on nicotine and tobacco. Cancer.
122:1150–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Youlden DR, Cramb SM and Baade PD: The
international epidemiology of lung cancer: Geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis-A look outside the nucleus. Science.
287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dihlmann S and von Knebel Doeberitz M:
Wnt/β-catenin-pathway as a molecular target for future anti-cancer
therapeutics. Int J Cancer. 113:515–524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LTD, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tetsu O and Mccormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
12
|
Chen G, Shukeir N, Potti A, Sircar K,
Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and
beta-catenin production in patients with advanced metastatic
prostate carcinoma: Potential pathogenetic and prognostic
implications. Cancer. 101:1345–1356. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang WM, Lo Muzio L, Rubini C and Yan G:
Effect of WNT-1 on β-catenin expression and its relation to Ki-67
and tumor differentiation in oral squamous cell carcinoma. Oncol
Rep. 13:1095–1099. 2005.PubMed/NCBI
|
|
14
|
Nguyen DX, Chiang AC, Zhang XHF, Kim JY,
Kris MG, Ladanyi M, Gerald WL and Massagu J: WNT/TCF signaling
through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Cell. 138:51–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baselga J: Targeting tyrosine kinases in
cancer: The second wave. Science. 312:1175–1178. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krause DS and Van Etten RA: Tyrosine
kinases as targets for cancer therapy. N Engl J Med. 353:172–187.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo PL, Huang YL, Hsieh CC, Lee JC, Lin BW
and Hung LY: STK31 is a cell cycle regulated protein that
contributes to the tumorigenicity of epithelial cancer cells. PLoS
One. 9:e933032014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhong L, Liu J, Hu Y, Wang W, Xu F, Xu W,
Han J and Biskup E: STK31 as novel biomarker of metastatic
potential and tumorigenicity of colorectal cancer. Oncotarget.
8:24354–24361. 2017.PubMed/NCBI
|
|
20
|
Watany MM, Elmashad NM, Badawi R and
Hawash N: Serum FBLN1 and STK31 as biomarkers of colorectal cancer
and their ability to noninvasively differentiate colorectal cancer
from benign polyps. Clin Chim Acta. 483:151–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong JY, Kang B, Kim A, Hwang S, Ahn J,
Lee S, Kim J, Park JH and Cheon DS: Development of a highly
sensitive real-time one step RT-PCR combined complementary locked
primer technology and conjugated minor groove binder probe. Virol
J. 8:330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nature Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lim JH, Park JW and Chun YS: Human arrest
defective 1 acetylates and activates β-Catenin, promoting lung
cancer cell proliferation. Cancer Res. 66:106772006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bouchard C, Dittrich O, Kiermaier A,
Dohmann K, Menkel A, Eilers M and Lüscher B: Regulation of cyclin
D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP
recruitment and histone acetylation at the cyclin D2 promoter.
Genes Dev. 15:2042–2047. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bhattacharya S and Ghosh MK: HAUSP
regulates c-MYC expression via de-ubiquitination of TRRAP. Cell
Oncol (Dordr). 38:265–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu J, Gong Y, Huang M, Lu C, Spitz MR and
Wu X: Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk
in Caucasians. Carcinogenesis. 28:350–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Lei DS, Wang XQ, Skog S and He Q:
Serum thymidine kinase 1 (STK1) is a prognostic and monitoring
factor in patients with non-small-cell lung cancer. Oncol Rep.
13:145–149. 2005.PubMed/NCBI
|
|
30
|
Carretero J, Medina PP, Pio R, Montuenga
LM and Sanchez-Cespedes M: Novel and natural knockout lung cancer
cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene.
23:4037–4040. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gill RK, Yang SH, Meerzaman D, Mechanic
LE, Bowman ED, Jeon HS, Roy Chowdhuri S, Shakoori A, Dracheva T,
Hong KM, et al: Frequent homozygous deletion of the LKB1/STK11 gene
in non-small cell lung cancer. Oncogene. 30:3784–3791. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Zhu W, Xiong L, Yu X, Chen X and Lin
Q: Role of high expression levels of STK39 in the growth, migration
and invasion of non-small cell type lung cancer cells. Oncotarget.
7:61366–61377. 2016.PubMed/NCBI
|
|
33
|
Gao Y, Song C, Hui L, Li CY, Wang J, Tian
Y, Han X, Chen Y, Tian DL, Qiu X and Wang E: Overexpression of
RNF146 in non-small cell lung cancer enhances proliferation and
invasion of tumors through the Wnt/β-catenin signaling pathway.
PLoS One. 9:e853772014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wan L, Zhang L, Fan K, Cheng ZX, Sun QC
and Wang JJ: Circular RNA-ITCH suppresses lung cancer proliferation
via inhibiting the Wnt/β-catenin pathway. Biomed Res Int.
2016:15794902016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miller DM, Thomas SD, Islam A, Muench D
and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res.
18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hall M and Peters G: Genetic alterations
of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human
cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lukas J, Bartkova J, Rohde M, Strauss M
and Bartek J: Cyclin D1 is dispensable for G1 control in
retinoblastoma gene-deficient cells independently of cdk4 activity.
Mol Cell Biol. 15:2600–2611. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
You Z, Saims D, Chen S, Zhang Z, Guttridge
DC, Guan KL, Macdougald OA, Brown AM, Evan G, Kitajewski J and Wang
CY: Wnt signaling promotes oncogenic transformation by inhibiting
c-Myc-induced apoptosis. J Cell Biol. 157:429–440. 2002. View Article : Google Scholar : PubMed/NCBI
|
